Evaluating the efficacy of an attention modification program for patients with fibromyalgia
| Autor: | Kadie Hozempa, Geert Crombez, R. Nicholas Carleton, Johan W.S. Vlaeyen, Joel Katz, Gordon J.G. Asmundson, Daniel M. LeBouthillier, Stephanie Korol |
|---|---|
| Přispěvatelé: | RS: FPN CPS I, Section Experimental Health Psychology |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Fibromyalgia
chronic musculoskeletal pain Attentional bias Anxiety psychometric properties law.invention pain-related information Attentional Bias 0302 clinical medicine Randomized controlled trial MODIFIED STROOP PARADIGM 030202 anesthesiology law special section ANXIETY-STRESS SCALES BIAS MODIFICATION Attention modification Chronic pain Fear Middle Aged anxiety Neurology fear Female fibromyalgia medicine.symptom attention modification Adult medicine.medical_specialty Chronic musculoskeletal pain selective attention SOCIAL ANXIETY MEDLINE 03 medical and health sciences Double-Blind Method Reaction Time medicine Humans DEPRESSION-ANXIETY Protocol (science) Cognitive Behavioral Therapy business.industry medicine.disease Anesthesiology and Pain Medicine Physical therapy Anxiety sensitivity Self Report Neurology (clinical) business 030217 neurology & neurosurgery Follow-Up Studies |
| Zdroj: | Pain, 161(3), 584-594. LIPPINCOTT WILLIAMS & WILKINS |
| ISSN: | 0304-3959 |
| DOI: | 10.1097/j.pain.0000000000001746 |
| Popis: | Persons with chronic musculoskeletal pain may be hypervigilant for pain-related cues, which paradoxically, may be maintaining their pain. Several randomized controlled trials have assessed whether a modified dot-probe protocol (i.e., attention bias modification; ABM) reduces chronic pain- and pain-related symptoms in persons with several diagnoses, including fibromyalgia. Scalability and economic efficiency potentiates the appeal of ABM protocols; however, research results have been mixed, with only some studies evidencing significant symptom gains from ABM and some evidencing gains for the control group. The current randomized controlled trial sought to replicate and extend previous ABM research using idiosyncratic word stimuli and a 1-month follow-up. Participants included treatment-seeking adult women (n=117) with fibromyalgia who were randomly assigned to a standard (i.e., control) or active (i.e., ABM) condition. The protocol was delivered online and involved twice-weekly 15-min sessions, for 4 weeks, with questionnaires completed at baseline, post-treatment, and 1-month follow-up. Symptom reports were analysed with mixed hierarchical modelling. There was no evidence of differences between the control and ABM groups. Both groups had small significant (ps.05). There were no significant changes for either group on measures of anxiety sensitivity, illness/injury sensitivity, pain-related fear, pain-related anxiety, or attentional biases (ps>.05). The current findings add to the emerging and mixed literature regarding ABM for pain by demonstrating that ABM produces no substantive improvements in pain or pain-related constructs in a large sample of patients with fibromyalgia. ispartof: Pain vol:161 issue:3 pages:584-594 ispartof: location:United States status: published |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|